PMEF
Point72 Middle East FZE Portfolio holdings
AUM
$1.44B
1-Year Return
6.39%
This Quarter Return
+4.46%
1 Year Return
+6.39%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.44B
AUM Growth
-$210M
(-13%)
Cap. Flow
-$309M
Cap. Flow
% of AUM
-21.4%
Top 10 Holdings %
Top 10 Hldgs %
14.61%
Holding
1,494
New
525
Increased
162
Reduced
203
Closed
485
Top Buys
| 1 |
UnitedHealth
UNH
|
+$23M |
| 2 |
Humana
HUM
|
+$22.4M |
| 3 |
Amazon
AMZN
|
+$21M |
| 4 |
Micron Technology
MU
|
+$19.4M |
| 5 |
Synopsys
SNPS
|
+$18.9M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$30.9M |
| 2 |
Union Pacific
UNP
|
+$29.5M |
| 3 |
Meta Platforms (Facebook)
META
|
+$25.8M |
| 4 |
Nike
NKE
|
+$25.5M |
| 5 |
CVS Health
CVS
|
+$25.1M |
Sector Composition
| 1 | Technology | 22.49% |
| 2 | Healthcare | 16.32% |
| 3 | Consumer Discretionary | 14.56% |
| 4 | Financials | 12.23% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
801
ThredUp
TDUP
$1.3B
| $25.7K | ﹤0.01% |
+11,430
| New | +$25.7K |
|
802
Design Therapeutics
DSGN
$356M
| $25K | ﹤0.01% |
9,426
+4,501
| +91% | +$11.9K |
|
803
Janus International
JBI
$1.39B
| $24.5K | ﹤0.01% |
1,880
-27,988
| -94% | -$365K |
|
|
MAG
804
DELISTED
MAG Silver
MAG
| $24.5K | ﹤0.01% |
+2,352
| New | +$24.5K |
|
805
Zeta Global
ZETA
$4.51B
| $24.3K | ﹤0.01% |
+2,753
| New | +$24.3K |
|
|
PGRE
806
Paramount Group
PGRE
$1.6B
| $23.6K | ﹤0.01% |
+4,566
| New | +$23.6K |
|
|
TPC
807
Tutor Perini Corporation
TPC
$3.28B
| $22.9K | ﹤0.01% |
2,518
-2,074
| -45% | -$18.9K |
|
|
OKUR
808
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$33.6M
| $22.3K | ﹤0.01% |
+1,395
| New | +$22.3K |
|
809
RE/MAX Holdings
RMAX
$186M
| $21.9K | ﹤0.01% |
1,641
-4,103
| -71% | -$54.7K |
|
810
Aveanna Healthcare
AVAH
$1.7B
| $20.8K | ﹤0.01% |
7,766
+1,877
| +32% | +$5.03K |
|
811
Brady Corp
BRC
$3.68B
| $20.2K | ﹤0.01% |
345
-110
| -24% | -$6.46K |
|
812
Preformed Line Products
PLPC
$954M
| $19.9K | ﹤0.01% |
+149
| New | +$19.9K |
|
|
DRD
813
DRDGold
DRD
$1.97B
| $19.7K | ﹤0.01% |
+2,484
| New | +$19.7K |
|
814
Alto Ingredients
ALTO
$89.8M
| $19.6K | ﹤0.01% |
7,366
| – | – |
|
815
Karyopharm Therapeutics
KPTI
$55.7M
| $19.1K | ﹤0.01% |
1,469
-4,874
| -77% | -$63.2K |
|
816
Global Industrial
GIC
$1.43B
| $18.8K | ﹤0.01% |
+485
| New | +$18.8K |
|
817
Semler Scientific
SMLR
$423M
| $18.8K | ﹤0.01% |
+424
| New | +$18.8K |
|
818
Atara Biotherapeutics
ATRA
$82.8M
| $18.2K | ﹤0.01% |
+1,421
| New | +$18.2K |
|
|
PSTX
819
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $17.9K | ﹤0.01% |
+5,341
| New | +$17.9K |
|
820
Pennant Group
PNTG
$840M
| $17.8K | ﹤0.01% |
1,280
-2,324
| -64% | -$32.4K |
|
821
Latham Group
SWIM
$922M
| $17.8K | ﹤0.01% |
6,770
+4,250
| +169% | +$11.2K |
|
|
PSTL
822
Postal Realty Trust
PSTL
$390M
| $17.6K | ﹤0.01% |
+1,210
| New | +$17.6K |
|
823
Allient
ALNT
$770M
| $17.6K | ﹤0.01% |
+583
| New | +$17.6K |
|
824
Gentherm
THRM
$1.07B
| $16.3K | ﹤0.01% |
312
-1,461
| -82% | -$76.5K |
|
825
Lindblad Expeditions
LIND
$715M
| $15.6K | ﹤0.01% |
+1,381
| New | +$15.6K |
|